Nestlé Health Science Invests in Aimmune

News   Nov 07, 2016

 
Nestlé Health Science Invests in Aimmune
 
 
 

RELATED ARTICLES

Salmonella Cases No Longer Declining in the EU

News

The declining trend of salmonellosis cases in the EU has levelled off according to the annual report on zoonotic diseases. Cases of Salmonella Enteritidis acquired in the EU have increased in humans by 3% since 2014 and in laying hens, the prevalence increased from 0.7% to 1.21% over the same period.

READ MORE

Anti-Stress Compound Reduces Obesity and Diabetes

News

Researchers find a stress protein found in muscle has a diabetes promoting effect

READ MORE

British Pharmacological Society’s Drug Discovery of the Year 2018 Announced

News

A new medicine used to treat an ultra-rare inherited disorder which leaves babies without a fully functioning immune system has been named the British Pharmacological Society’s Drug Discovery of the Year 2018.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE